CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Sarepta names former AbbVie R&D exec Michael Severino as next CEO

Neutral
AI Analysis

Summary

Sarepta Therapeutics appoints Michael Severino, former AbbVie R&D executive, as its next CEO. The appointment comes as Sarepta awaits two key regulatory decisions in Duchenne muscular dystrophy.

Importance:5/10
Sentiment:
0.00
leadership changeCEO appointmentregulatory decisions pendingDuchenne muscular dystrophy
Related Companies

Read the original article

Published by BioSpace on July 27, 2026 2:20 PM

Read Original